FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286493974> ?p ?o ?g. }

• W4286493974 endingPage "1421" @default.
• W4286493974 startingPage "1415" @default.
• W4286493974 abstract "At present, standardized parameters for quantitatively evaluating 68 Ga-PSMA-PET/CT outcomes when diagnosing lymph node metastasis in prostate cancer patients are lacking. Inflammatory hematological biomarkers offer value as robust predictors of certain cancer-related outcomes. The present study was thus developed to explore approaches to improving the utility of 68 Ga-PSMA-PET/CT for diagnosing lymph node metastasis through the combined evaluation of inflammatory hematological markers in prostate cancer patients.Pretreatment patient details including age, initial TPSA levels, hematological findings, biopsy pathology results (Gleason score and ISUP grouping), radical pathology results, and imaging details were collected. Optimal cutoff values for each predictor then being determined based upon Youden's index, with univariate and multivariate analyses were then used to identify independent predictors of lymph node metastasis and used to construct a nomogram.Independent predictors of lymph node metastasis in this patient cohort included SUVmax (odds ratio [OR]: 30.549, 95% confidence interval [CI]: 10.855-85.973, p < 0.001), neutrophil-lymphocyte ratio (OR:8.221, 95%CI: 1.335-50.614, p = 0.023), platelet-lymphocyte ratio (OR:8.221, 95% CI: 1.335-50.614, p = 0.023), initial TPSA (OR:2.761, 95% CI: 1.132-6.733, p = 0.026), and clinical T-stage (T3 vs. T2, OR:11.332, 95% CI:3.929-32.681, p < 0.001; T4 vs. T2, OR:9.101, 95% CI:1.962-42.213, p = 0.005), with corresponding optimal cutoff values of 2.3 (area under the curve [AUC]: 0.873, sensitivity: 0.736, specificity: 0.902), 1.72 (AUC: 0.558, sensitivity: 0.529, specificity: 0.643), 83.305 (AUC: 0.651, sensitivity: 0.299, specificity: 0.979), and 21.875 (AUC: 0.672, sensitivity: 0.736, specificity: 0.601). Subsequent nomogram construction was associated with good predictive ability, with a C-index of 0.887(95% CI: 0.793-0.981) and an AUC of 0.924 (95% CI: 0.882-0.965).SUVmax, the neutrophil-lymphocyte ratio, the platelet-lymphocyte ratio, initial TPSA, and clinical T-stage represent valuable independent predictors of lymph node metastasis in prostate cancer patients, offering an opportunity to further optimize lymph node staging for these patients." @default.
• W4286493974 created "2022-07-22" @default.
• W4286493974 creator A5008249437 @default.
• W4286493974 creator A5020458763 @default.
• W4286493974 creator A5038907190 @default.
• W4286493974 creator A5039589213 @default.
• W4286493974 creator A5048881400 @default.
• W4286493974 creator A5052000728 @default.
• W4286493974 creator A5053927760 @default.
• W4286493974 date "2022-07-21" @default.
• W4286493974 modified "2023-10-02" @default.
• W4286493974 title "Optimization of prostate cancer patient lymph node staging via the integration of neutrophil–lymphocyte ratios, platelet–lymphocyte ratios, and ⁶⁸Ga‐PSMA‐PET‐derived SUVmax values" @default.
• W4286493974 cites W1597643123 @default.
• W4286493974 cites W1973942000 @default.
• W4286493974 cites W1988082986 @default.
• W4286493974 cites W2009821632 @default.
• W4286493974 cites W2012043017 @default.
• W4286493974 cites W2074306582 @default.
• W4286493974 cites W2080928007 @default.
• W4286493974 cites W2123105952 @default.
• W4286493974 cites W2127082932 @default.
• W4286493974 cites W2233823492 @default.
• W4286493974 cites W2326657743 @default.
• W4286493974 cites W2326988718 @default.
• W4286493974 cites W2580862866 @default.
• W4286493974 cites W2582140819 @default.
• W4286493974 cites W2612014481 @default.
• W4286493974 cites W2743412658 @default.
• W4286493974 cites W2765650591 @default.
• W4286493974 cites W2767976593 @default.
• W4286493974 cites W2893389698 @default.
• W4286493974 cites W2897236707 @default.
• W4286493974 cites W2920107756 @default.
• W4286493974 cites W2945239299 @default.
• W4286493974 cites W2947226032 @default.
• W4286493974 cites W2959497269 @default.
• W4286493974 cites W3005433692 @default.
• W4286493974 cites W3006074479 @default.
• W4286493974 cites W3007640689 @default.
• W4286493974 cites W3097158220 @default.
• W4286493974 cites W3158162609 @default.
• W4286493974 cites W3162348349 @default.
• W4286493974 cites W3185807027 @default.
• W4286493974 cites W3200578511 @default.
• W4286493974 cites W3200619821 @default.
• W4286493974 cites W3201450367 @default.
• W4286493974 cites W3201577472 @default.
• W4286493974 cites W3215352516 @default.
• W4286493974 cites W4214672256 @default.
• W4286493974 doi "https://doi.org/10.1002/pros.24415" @default.
• W4286493974 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35860907" @default.
• W4286493974 hasPublicationYear "2022" @default.
• W4286493974 type Work @default.
• W4286493974 citedByCount "4" @default.
• W4286493974 countsByYear W42864939742022 @default.
• W4286493974 countsByYear W42864939742023 @default.
• W4286493974 crossrefType "journal-article" @default.
• W4286493974 hasAuthorship W4286493974A5008249437 @default.
• W4286493974 hasAuthorship W4286493974A5020458763 @default.
• W4286493974 hasAuthorship W4286493974A5038907190 @default.
• W4286493974 hasAuthorship W4286493974A5039589213 @default.
• W4286493974 hasAuthorship W4286493974A5048881400 @default.
• W4286493974 hasAuthorship W4286493974A5052000728 @default.
• W4286493974 hasAuthorship W4286493974A5053927760 @default.
• W4286493974 hasConcept C121608353 @default.
• W4286493974 hasConcept C126322002 @default.
• W4286493974 hasConcept C143998085 @default.
• W4286493974 hasConcept C144301174 @default.
• W4286493974 hasConcept C156957248 @default.
• W4286493974 hasConcept C2777761686 @default.
• W4286493974 hasConcept C2779013556 @default.
• W4286493974 hasConcept C2780192828 @default.
• W4286493974 hasConcept C2780849966 @default.
• W4286493974 hasConcept C34626388 @default.
• W4286493974 hasConcept C38180746 @default.
• W4286493974 hasConcept C44249647 @default.
• W4286493974 hasConcept C58471807 @default.
• W4286493974 hasConcept C71924100 @default.
• W4286493974 hasConceptScore W4286493974C121608353 @default.
• W4286493974 hasConceptScore W4286493974C126322002 @default.
• W4286493974 hasConceptScore W4286493974C143998085 @default.
• W4286493974 hasConceptScore W4286493974C144301174 @default.
• W4286493974 hasConceptScore W4286493974C156957248 @default.
• W4286493974 hasConceptScore W4286493974C2777761686 @default.
• W4286493974 hasConceptScore W4286493974C2779013556 @default.
• W4286493974 hasConceptScore W4286493974C2780192828 @default.
• W4286493974 hasConceptScore W4286493974C2780849966 @default.
• W4286493974 hasConceptScore W4286493974C34626388 @default.
• W4286493974 hasConceptScore W4286493974C38180746 @default.
• W4286493974 hasConceptScore W4286493974C44249647 @default.
• W4286493974 hasConceptScore W4286493974C58471807 @default.
• W4286493974 hasConceptScore W4286493974C71924100 @default.
• W4286493974 hasFunder F4320316344 @default.
• W4286493974 hasFunder F4320321001 @default.
• W4286493974 hasIssue "15" @default.
• W4286493974 hasLocation W42864939741 @default.
• W4286493974 hasLocation W42864939742 @default.
• W4286493974 hasOpenAccess W4286493974 @default.

• next